Future for biological therapy for uveitis-Reference-Cited by-同舟云学术

Future for biological therapy for uveitis

Published:2010-11 Issue:6 Volume:21 Page:473-477
ISSN:1040-8738
Container-title:Current Opinion in Ophthalmology
language:en
Short-container-title:

Author:

Rosenbaum James T

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference43 articles.

1. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation;Galor;Ophthalmology,2006

2. Effect of infliximab on sight-threatening panuveitis in Behçet's disease;Sfikakis;Lancet,2001

3. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis;Ohno;J Rheumatol,2004

4. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes;Suhler;Arch Ophthalmol,2005

5. Infliximab therapy for refractory uveitis: 2-year results of a prospective trial;Suhler;Arch Ophthalmol,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overexpressing Kallistatin Aggravates Experimental Autoimmune Uveitis Through Promoting Th17 Differentiation;Frontiers in Immunology;2021-10-18

2. Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Ace Card to Address Autoimmune Diseases;International Journal of Stem Cells;2020-03-30

3. Effects of Mesenchymal Stem Cell-Derived Exosomes on Experimental Autoimmune Uveitis;Scientific Reports;2017-06-28

4. The Eye and Rheumatic Diseases;Kelley and Firestein's Textbook of Rheumatology;2017

5. Anti-inflammatory effect of conditioned medium from human uterine cervical stem cells in uveitis;Experimental Eye Research;2016-08